General Release Of All Claims Sample Contracts

Share Cite Term
Link

Embed (HTML)
Separation Agreement and General Release of All Claims (June 6th, 2017)

This Separation Agreement and General Release of All Claims ("Separation Agreement") is made by and between Ideal Power Inc. ("Company") and Ryan O'Keefe ("Employee") with respect to the following facts:

Separation Agreement With General Release of All Claims (March 10th, 2017)

This Separation Agreement With General Release of All Claims ("Agreement") is entered into by and between David C. Dreyer ("Mr. Dreyer"), and Biolase, Inc., a Delaware corporation (the "Company"), and is intended by the parties hereto to settle fully and finally any claims that Mr. Dreyer may have against the Company and all obligations of the Company to Mr. Dreyer, except as set forth in and incorporated into this Agreement.

Waiver and Non-Competition Agreement and General Release of All Claims (January 6th, 2016)

This Waiver and Non-Competition Agreement and General Release ("Agreement") is entered into by Manuel Rivelo ("Employee") and F5 Networks, Inc. ("Company" or "Employer").

General Release of All Claims (September 5th, 2014)

This General Release of All Claims ("Release") is made by and between John Warwick ("Executive") on the one hand and Maxwell Technologies, Inc. (the "Company") on the other. (Collectively, Executive and the Company shall be referred to as the "Parties.")

General Release of All Claims and Standstill Agreement (June 27th, 2014)

This General Release of All Claims and Standstill Agreement (this "Agreement") is entered into by James J. Connor (the "Executive") and Tecumseh Products Company (the "Company"), in connection with the termination of the Executive's employment with the Company as of June 27, 2014 ("Termination Date").

General Release of All Claims (March 7th, 2013)

This General Release of All Claims (this "Agreement") is entered into by Michael A. Noelke (the "Executive") and Tecumseh Products Company (the "Company") in connection with his resignation from employment with the Company as of March 6, 2013 (the "Effective Date").

General Release of All Claims (February 27th, 2013)
Separation Agreement, General Release of All Claims and Covenant Not to Sue (February 12th, 2013)

THIS AGREEMENT (the Agreement) is entered into as of the Effective Date, as defined in Section 9 hereof, by and between FARO TECHNOLOGIES, INC., a Florida corporation (the Company) and David Morse (Employee).

Lodgenet – Lodgenet Healthcare, Inc. Executive Employment Agreement (June 27th, 2012)

AGREEMENT, effective as of January 1, 2012 by and between LodgeNet Healthcare, Inc., a Delaware corporation located at 3900 West Innovation Street, Sioux Falls, South Dakota 57107 (Corporation), and Gary L. Kolbeck (Executive).

The Company Hereby Employs Executive on an at Will Basis. Each of the Company and the Executive May at Any Time on 30 Days' Notice Terminate the Employment of the Executive for Any Reason or for No Reason. The Date on Which Executive's Employment Terminates Is the Termination Date. The Executive Hereby Agrees That He Shall Also Be Deemed to Have Resigned as an Executive, Officer, Employee and Director of the Company Effective as of the Termination Date. The Company Shall Pay to the Executive Twelve Monthly Payments of $14,583.33 Less Withholding Taxes as Severance if and Only if the Company Te (December 2nd, 2011)
August 17, 2011 Kevin T. Biggs Dear Kevin, (August 22nd, 2011)

This letter (the Agreement) is to confirm the agreement between you and Blue Coat Systems, Inc. (the Company) regarding the termination of your employment with the Company. Your employment with the Company will be terminated August 19, 2011 (Termination Date). Although you are not otherwise entitled to receive any severance benefits from the Company, after you sign this Agreement the Company will pay you a lump sum severance payment in the amount of $150,000, which is equal to 6 months base salary, less all applicable withholdings (the Severance Payment). Your coverage under the group plans of Blue Coat will end on the last day of the month in which your termination date occurs. You will receive information on COBRA directly from ClearBenefits.

Transition Agreement, Separation Agreement and General Release of All Claims (July 15th, 2011)

This Transition Agreement, Separation Agreement and General Release of all Claims (Agreement) is entered into on July 14, 2011 between Coeur dAlene Mines Corporation (Company) and Dennis E. Wheeler (Executive) (each of the foregoing individually a Party and collectively the Parties).

Grubb & Ellis – Separation Agreement and General Release of All Claims (June 16th, 2011)

This Separation Agreement and General Release of all Claims (Agreement) is made by and between Mathieu B. Streiff (Employee) and Grubb & Ellis Company (Grubb & Ellis or the Company) (collectively, the Parties).

General Release of All Claims (May 10th, 2011)

This General Release of All Claims (this Agreement) is entered into by James E. Wainright (the Executive) and Tecumseh Products Company (the Company), in connection with the termination of the Executives employment with the Company as of the date that is mutually acceptable by the Executive and the Company (Termination Date).

May 4, 2011 (May 5th, 2011)

We have discussed your continuing role with Blue Coat Systems, Inc. (the Company) after the Companys re-alignment of its research and development organization and product groups. This letter (the Agreement) is to confirm the agreement between you and Blue Coat Systems, Inc., (the Company) regarding your ceasing to serve as a senior executive of the Company and the termination of your employment with the Company.

May 4, 2011 (May 5th, 2011)

We have discussed your continuing role with Blue Coat Systems, Inc. (the Company) after the Companys re-alignment of its research and development organization and product groups. This letter (the Agreement) is to confirm the agreement between you and Blue Coat Systems, Inc., (the Company) regarding your ceasing to serve as a senior executive of the Company and the termination of your employment with the Company.

IVAX Diagnostics, Inc. – Confidential General Release of All Claims (March 30th, 2011)

This Confidential General Release of All Claims ("Agreement") is entered into between IVAX DIAGNOSTICS, INC., along with its parents (including, without limitation, Erba Diagnostics Mannheim GmbH), predecessors, successors, subsidiaries (including, without limitation, Delta Biologicals, S.r.l, ImmunoVision, Inc. and Diamedix Corporation), affiliates, related entities, divisions, assigns, and all of its and their current, former, and future owners, officers, directors, shareholders, investors, members, employees, consultants, attorneys, insurers, and assigns (collectively "IVD"), and CHARLES R. STRUBY, Ph.D., along with his heirs, successors, and assigns (collectively "STRUBY"), on the date ascribed below.

Separation Agreement and General Release of All Claims (March 11th, 2011)

This Separation Agreement and General Release of All Claims (Separation Agreement) is made by and between Halozyme Therapeutics, Inc. (Halozyme) and Jonathan E. Lim (Employee) as of December 2, 2010 with respect to the following facts:

Cherokee Inc. – Separation Agreement and General Release of All Claims (January 31st, 2011)

THIS SEPARATION AGREEMENT AND GENERAL RELEASE OF ALL CLAIMS (this Agreement) is made by and among The Newstar Group d.b.a. The Wilstar Group (Wilstar), Robert Margolis (Executive) and Cherokee Inc. (Cherokee or the Company) (collectively, the Parties) and is dated as of January 28, 2011.

John B. Sanfilippo & Son, Inc. – Form of Change-Of-Control Employment Security Agreement and Non-Compete (January 31st, 2011)

AGREEMENT, by and between John B. Sanfilippo & Son, Inc., a Delaware corporation (the Company), and [] (the Executive), dated as of the [] day of [], 20[] (this Agreement).

Confidential General Release of All Claims (January 14th, 2011)

This CONFIDENTIAL GENERAL RELEASE OF ALL CLAIMS (the Release) is entered into this14th day of January 2011 (the Effective Date), by and among SafeStitch Medical, Inc., and its agents, servants, parent companies, officers, directors, predecessors, subsidiaries, divisions and successors, along with its and their current and former employees, attorneys, officers, directors and agents, both individually and in their business capacities (hereinafter collectively referred to as Employer) and Adam S. Jackson, his heirs, successors and assigns (hereinafter referred to as Employee).

Trucept Inc. – GENERAL RELEASE OF ALL CLAIMS (The Release) (December 13th, 2010)

IN CONSIDERATION of the all inclusive sum of $45,000, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, RICHARDSON PATEL LLP does for itself and its agents, successors, and assigns (the Releasor), agree to the following:

Confidential General Release of All Claims (December 1st, 2010)

This CONFIDENTIAL GENERAL RELEASE OF ALL CLAIMS (the Release) is entered into by and among SafeStitch Medical, Inc., and its agents, servants, parent companies, officers, directors, predecessors, subsidiaries, divisions, affiliates, and successors, along with its and their current and former employees, attorneys, officers, directors and agents, both individually and in their business capacities (hereinafter collectively referred to as Employer) and Stewart B. Davis, M.D., his heirs, successors and assigns (hereinafter referred to as Employee).

IVAX Diagnostics, Inc. – Confidential General Release of All Claims (November 15th, 2010)

This Confidential General Release of All Claims ("Agreement") is entered into between IVAX DIAGNOSTICS, INC., along with its parents (including, without limitation, Erba Diagnostics Mannheim GmbH), predecessors, successors, subsidiaries (including, without limitation, Delta Biologicals, S.r.l, ImmunoVision, Inc. and Diamedix Corporation), affiliates, related entities, divisions, assigns, and all of its and their current, former, and future owners, officers, directors, shareholders, investors, members, employees, consultants, attorneys, insurers, and assigns (collectively "IVD"), and STEVE E. LUFKIN, along with his heirs, successors, and assigns (collectively "LUFKIN"), on the date ascribed below.

Grubb & Ellis – Separation Agreement and General Release of All Claims (October 28th, 2010)

This Separation Agreement and General Release of all Claims (Agreement) is made by and between Andrea R. Biller (Employee) and Grubb & Ellis Company (the Parent Company), including all of Parent Companys current and former parents, subsidiaries, affiliates and related entities (all current and former parents, subsidiaries, affiliates and related entities, along with the Parent Company, are collectively referred to as Grubb & Ellis).

September 7, 2010 6831 Prestonshire Lane Dallas, Texas 75225 Dear Tom: (September 13th, 2010)

This letter serves to confirm the terms of our agreement regarding your voluntary separation from employment with Blockbuster Inc. Your effective termination date will be September 11, 2010. Until such time, you will continue to receive your current salary in accordance with Blockbusters normal payroll practices as well as employee benefits. You will receive a lump sum payment for any accrued but unused paid time off (PTO), less ordinary withholding tax by the next regularly scheduled payday following termination of your employment. Your separation is pursuant to the terms of your Amended and Restated Employment Agreement, dated May 17, 2010 (your Employment Agreement, subject to the following modifications:

Transition, Separation Agreement and General Release of All Claims (September 9th, 2010)

This Transition Separation Agreement and General Release of all Claims (Agreement) is made by and between Scott T. Garrett (Executive) and Beckman Coulter, Inc. (Beckman Coulter) (collectively, the Parties).

August 30, 2010 Dear Mike: (August 31st, 2010)

I am pleased to offer you a position with Blue Coat Systems, Inc. (the Company) as President and Chief Executive Officer, reporting to the Companys Board of Directors. In this role you will be expected to perform such duties as are consistent with your title and position, as well as any other reasonable duties determined by the Companys Board of Directors. We anticipate that you will commence employment with the Company on September 1, 2010.

Termination Agreement and General Release of All Claims (July 23rd, 2010)

This Termination Agreement and General Release (the "Agreement") is entered into by and between Quantum Corporation, a Delaware corporation (Quantum or Company), and Gerald G. Lopatin (Mr. Lopatin), collectively, (the Parties).

Grubb & Ellis – Consulting and Separation Agreement and General Release of All Claims (May 4th, 2010)

This Separation Agreement and General Release of all Claims (Agreement) is made by and between Richard Pehlke (Employee) and Grubb & Ellis Company (Grubb & Ellis) (collectively, the Parties).

General Release of All Claims (March 11th, 2010)

This General Release of All Claims (this Agreement) is entered into by James Nicholson (the Executive) and Tecumseh Products Company (the Company), effective as of January 19, 2010, in connection with the termination of the Executives employment with the Company as of December 31, 2009.

Lodgenet – Lodgenet Interactive Corporation Executive Employment Agreement (March 2nd, 2010)

AGREEMENT, dated as of February 25, 2010 by and between LodgeNet Interactive Corporation, a Delaware corporation located at 3900 West Innovation Street, Sioux Falls, South Dakota 57107 (Corporation), and Frank Elsenbast (Executive).

Adamis Pharmaceuticl – Retention and Separation Agreement and General Release of All Claims (December 7th, 2009)

This Retention and Separation Agreement and General Release of All Claims (Agreement) is made by and between La Jolla Pharmaceutical Company (LJPC) and Gail Sloan (Sloan) with respect to the following facts:

La Jolla Pharmaceutical Company – Retention and Separation Agreement and General Release of All Claims (December 7th, 2009)

This Retention and Separation Agreement and General Release of All Claims (Agreement) is made by and between La Jolla Pharmaceutical Company (LJPC) and Deirdre Y. Gillespie M.D. (Gillespie) with respect to the following facts:

La Jolla Pharmaceutical Company – Retention and Separation Agreement and General Release of All Claims (December 7th, 2009)

This Retention and Separation Agreement and General Release of All Claims (Agreement) is made by and between La Jolla Pharmaceutical Company (LJPC) and Gail Sloan (Sloan) with respect to the following facts: